HK1060357A1 - Beta-lactam compounds, process for reproducing thesame and serum cholesterol-lowering agents contai ning the same - Google Patents
Beta-lactam compounds, process for reproducing thesame and serum cholesterol-lowering agents contai ning the sameInfo
- Publication number
- HK1060357A1 HK1060357A1 HK04103348A HK04103348A HK1060357A1 HK 1060357 A1 HK1060357 A1 HK 1060357A1 HK 04103348 A HK04103348 A HK 04103348A HK 04103348 A HK04103348 A HK 04103348A HK 1060357 A1 HK1060357 A1 HK 1060357A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- group
- carbon atoms
- chain
- thesame
- reproducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001048202 | 2001-02-23 | ||
JP2001128031 | 2001-04-25 | ||
PCT/JP2002/001481 WO2002066464A1 (en) | 2001-02-23 | 2002-02-20 | β-LACTAM COMPOUNDS, PROCESS FOR REPODUCING THE SAME AND SERUM CHOLESTEROL-LOWERING AGENTS CONTAINING THE SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1060357A1 true HK1060357A1 (en) | 2004-08-06 |
Family
ID=26609978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04103348A HK1060357A1 (en) | 2001-02-23 | 2004-05-12 | Beta-lactam compounds, process for reproducing thesame and serum cholesterol-lowering agents contai ning the same |
Country Status (18)
Country | Link |
---|---|
US (1) | US7045515B2 (ja) |
EP (1) | EP1362855B1 (ja) |
JP (1) | JP4229701B2 (ja) |
KR (1) | KR100721639B1 (ja) |
CN (1) | CN1273467C (ja) |
AT (1) | ATE374769T1 (ja) |
AU (1) | AU2002237522B2 (ja) |
BR (1) | BRPI0206193B1 (ja) |
CA (1) | CA2438961C (ja) |
DE (1) | DE60222742T2 (ja) |
DK (1) | DK1362855T3 (ja) |
ES (1) | ES2294101T3 (ja) |
HK (1) | HK1060357A1 (ja) |
MX (1) | MXPA03005073A (ja) |
PT (1) | PT1362855E (ja) |
RU (1) | RU2301799C2 (ja) |
TW (1) | TWI291957B (ja) |
WO (1) | WO2002066464A1 (ja) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ527852A (en) | 2001-03-28 | 2005-03-24 | Schering Corp | Enantioselective synthesis of azetidinone intermediate compounds |
GB0215579D0 (en) * | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
JP2005015434A (ja) * | 2003-06-27 | 2005-01-20 | Kotobuki Seiyaku Kk | 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤 |
JP2007509963A (ja) * | 2003-10-30 | 2007-04-19 | メルク エンド カムパニー インコーポレーテッド | 抗高コレステロール血漿薬としての2−アゼチジノン |
EP1918000A2 (en) | 2003-11-05 | 2008-05-07 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
PL1682499T3 (pl) * | 2003-11-10 | 2008-01-31 | Microbia Inc | 4-Biarylilo-1-fenyloazetydyn-2-ony |
SI1682499T1 (sl) * | 2003-11-10 | 2008-02-29 | Microbia Inc | 4-biarilil-1-fenilazetidin-2-oni |
JP4688819B2 (ja) | 2003-12-23 | 2011-05-25 | アストラゼネカ アクチボラグ | コレステロール吸収阻害活性を有するジフェニルアゼチジノン誘導体 |
CN100471835C (zh) | 2003-12-23 | 2009-03-25 | 默克公司 | 抗高胆固醇血症化合物 |
BRPI0510150A (pt) * | 2004-05-21 | 2007-10-02 | Sanofi Aventis Deutschland | processo para preparação de derivados de 1,4-difenilacetidinonas |
CA2581596A1 (en) * | 2004-09-29 | 2006-04-13 | Schering Corporation | Combinations of substituted azetidonones and cb1 antagonists |
ES2435790T3 (es) | 2004-12-03 | 2013-12-23 | Intervet International B.V. | Piperazinas sustituidas como antagonistas de CB1 |
TW200726746A (en) * | 2005-05-06 | 2007-07-16 | Microbia Inc | Processes for production of 4-biphenylylazetidin-2-ones |
EA200702464A1 (ru) * | 2005-05-11 | 2008-04-28 | Майкробиа, Инк. | Способы получения фенольных 4-бифенилилазетидин-2-онов |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
BRPI0611415A2 (pt) * | 2005-05-25 | 2010-09-08 | Microbia Inc | ácidos fosfÈnicos de 4-(bifenilil)azetidin-2-ona e processo para a produção dos mesmos |
JP2008543837A (ja) * | 2005-06-15 | 2008-12-04 | メルク エンド カムパニー インコーポレーテッド | 抗高コレステロール血症化合物 |
WO2007001975A1 (en) | 2005-06-20 | 2007-01-04 | Schering Corporation | Piperidine derivatives useful as histamine h3 antagonists |
UY29607A1 (es) | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
AR057072A1 (es) | 2005-06-22 | 2007-11-14 | Astrazeneca Ab | Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto |
SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
TW200806623A (en) * | 2005-10-05 | 2008-02-01 | Merck & Co Inc | Anti-hypercholesterolemic compounds |
AR059021A1 (es) * | 2006-01-18 | 2008-03-05 | Schering Corp | Moduladores de receptores cannabinoides |
JP4880348B2 (ja) * | 2006-04-25 | 2012-02-22 | 壽製薬株式会社 | アズレン誘導体及びそれを有効成分とする血清コレステロール低下剤 |
AR060623A1 (es) | 2006-04-27 | 2008-07-02 | Astrazeneca Ab | Compuestos derivados de 2-azetidinona y un metodo de preparacion |
EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
CN101583612A (zh) * | 2006-09-15 | 2009-11-18 | 先灵公司 | 治疗脂质代谢障碍的氮杂环丁酮衍生物 |
US7638526B2 (en) * | 2006-09-15 | 2009-12-29 | Schering Corporation | Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
KR20090071589A (ko) | 2006-09-15 | 2009-07-01 | 쉐링 코포레이션 | 통증 및 지질 대사 장애의 치료에 유용한 아제티딘 및 아제티돈 유도체 |
MX2009002924A (es) * | 2006-09-15 | 2009-05-28 | Schering Corp | Derivados de azetidinona espirociclica para el tratamiento de trastornos del metabolismo de los lipidos, el dolor, la diabetes y otros trastornos. |
US20100035857A1 (en) * | 2006-12-20 | 2010-02-11 | Devita Robert J | Anti-hypercholesterolemic compounds |
DE102007005045B4 (de) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2008130616A2 (en) * | 2007-04-19 | 2008-10-30 | Schering Corporation | Diaryl morpholines as cb1 modulators |
MX2010000334A (es) * | 2007-06-28 | 2010-04-22 | Intervet Int Bv | Piperazinas sustituidas como antagonistas de cannabinoides 1. |
WO2009005671A2 (en) * | 2007-06-28 | 2009-01-08 | Schering Corporation | Substituted piperazines as cb1 antagonists |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
US20110245209A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
WO2010100255A1 (en) | 2009-03-06 | 2010-09-10 | Lipideon Biotechnology Ag | Pharmaceutical hypocholesterolemic compositions |
CN101993403B (zh) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | 氮杂环丁酮类化合物及医药应用 |
RU2012111354A (ru) | 2009-08-26 | 2013-10-10 | Санофи | Новые кристаллические гидраты фторгликозидов, содержащие их фармацевтические препараты и их использование |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683703B1 (de) | 2011-03-08 | 2015-05-27 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8846666B2 (en) | 2011-03-08 | 2014-09-30 | Sanofi | Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
CN104860980B (zh) * | 2015-04-23 | 2018-06-19 | 上海弈柯莱生物医药科技有限公司 | 一种用于合成依折麦布的中间体及其制备方法和应用 |
EP3942048A1 (en) | 2019-03-20 | 2022-01-26 | Regeneron Pharmaceuticals, Inc. | Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (srebf1) inhibitors |
CA3133002A1 (en) | 2019-03-20 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (scap) inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5857360A (ja) | 1981-10-01 | 1983-04-05 | Ajinomoto Co Inc | アゼチジノン誘導体 |
TW223059B (ja) * | 1991-07-23 | 1994-05-01 | Schering Corp | |
US5412092A (en) * | 1993-04-23 | 1995-05-02 | Bristol-Myers Squibb Company | N-substituted 2-azetidinones |
US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
WO1997016455A1 (en) * | 1995-10-31 | 1997-05-09 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
WO1997016424A1 (en) * | 1995-11-02 | 1997-05-09 | Schering Corporation | Process for preparing 1-(4-fluorophenyl)-3(r)-(3(s)-hydroxy-3-([phenyl or 4-fluorophenyl])-propyl)-4(s)-(4-hydroxyphenyl)-2-azetidinone |
DE50110906D1 (de) * | 2000-12-21 | 2006-10-12 | Sanofi Aventis Deutschland | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
-
2002
- 2002-02-08 TW TW091102310A patent/TWI291957B/zh not_active IP Right Cessation
- 2002-02-20 DK DK02703861T patent/DK1362855T3/da active
- 2002-02-20 PT PT02703861T patent/PT1362855E/pt unknown
- 2002-02-20 DE DE60222742T patent/DE60222742T2/de not_active Expired - Lifetime
- 2002-02-20 JP JP2002565979A patent/JP4229701B2/ja not_active Expired - Lifetime
- 2002-02-20 ES ES02703861T patent/ES2294101T3/es not_active Expired - Lifetime
- 2002-02-20 CA CA2438961A patent/CA2438961C/en not_active Expired - Fee Related
- 2002-02-20 KR KR1020037010927A patent/KR100721639B1/ko not_active IP Right Cessation
- 2002-02-20 WO PCT/JP2002/001481 patent/WO2002066464A1/ja active IP Right Grant
- 2002-02-20 EP EP02703861A patent/EP1362855B1/en not_active Expired - Lifetime
- 2002-02-20 BR BRPI0206193A patent/BRPI0206193B1/pt not_active IP Right Cessation
- 2002-02-20 US US10/450,171 patent/US7045515B2/en not_active Expired - Lifetime
- 2002-02-20 MX MXPA03005073A patent/MXPA03005073A/es active IP Right Grant
- 2002-02-20 AT AT02703861T patent/ATE374769T1/de active
- 2002-02-20 CN CNB028052013A patent/CN1273467C/zh not_active Expired - Fee Related
- 2002-02-20 AU AU2002237522A patent/AU2002237522B2/en not_active Ceased
- 2002-02-20 RU RU2003128424/04A patent/RU2301799C2/ru not_active IP Right Cessation
-
2004
- 2004-05-12 HK HK04103348A patent/HK1060357A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK1362855T3 (da) | 2008-01-28 |
MXPA03005073A (es) | 2003-09-05 |
DE60222742D1 (de) | 2007-11-15 |
BR0206193A (pt) | 2004-02-03 |
RU2301799C2 (ru) | 2007-06-27 |
CN1273467C (zh) | 2006-09-06 |
CA2438961C (en) | 2010-02-16 |
KR20030076690A (ko) | 2003-09-26 |
AU2002237522B2 (en) | 2007-08-02 |
TWI291957B (en) | 2008-01-01 |
ATE374769T1 (de) | 2007-10-15 |
JPWO2002066464A1 (ja) | 2004-06-17 |
WO2002066464A1 (en) | 2002-08-29 |
ES2294101T3 (es) | 2008-04-01 |
RU2003128424A (ru) | 2005-01-27 |
US7045515B2 (en) | 2006-05-16 |
BRPI0206193B1 (pt) | 2016-05-24 |
CA2438961A1 (en) | 2002-08-29 |
PT1362855E (pt) | 2007-12-04 |
JP4229701B2 (ja) | 2009-02-25 |
KR100721639B1 (ko) | 2007-05-23 |
EP1362855B1 (en) | 2007-10-03 |
CN1492865A (zh) | 2004-04-28 |
DE60222742T2 (de) | 2008-07-17 |
EP1362855A4 (en) | 2005-02-23 |
EP1362855A1 (en) | 2003-11-19 |
US20040063929A1 (en) | 2004-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1060357A1 (en) | Beta-lactam compounds, process for reproducing thesame and serum cholesterol-lowering agents contai ning the same | |
DE69518627D1 (de) | Pharmazeutisch wirksame verbindungen und liposome und verfahren zu deren herstellung | |
PT798295E (pt) | Novo derivado de amidinonaftilo ou sal deste | |
DE69430730D1 (de) | Hepatobillianische magnetische resonanz-kontrastmittel | |
TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
IL150650A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
DE60139025D1 (de) | Alkansäurederivate, verfahren zu deren herstellung und deren verwendung | |
HUP0000449A2 (hu) | N-szubsztituált dioxo-tiazolidil-benzamid-származékok és eljárás a vegyületek előállítására | |
EP0787726A4 (ja) | ||
MXPA04004982A (es) | Derivados de benzotiazol. | |
DE69529619D1 (en) | Pyrimidinylpyrazolderivate | |
ATE285238T1 (de) | Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl- phenol derivaten | |
EP1147772A4 (en) | DRUG COMPOSITIONS FOR THE TREATMENT OF EAR FIBRILLATION | |
UA66888C2 (uk) | 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів | |
KR930003911A (ko) | 치환된 방향족 아미드 잔기를 갖는 아미노카르복실레이트 리간드 | |
HUP0003475A2 (hu) | Neutrofil-elasztáz gátló hatású pirrolo-pirrolon-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
MXPA04002838A (es) | Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170220 |